Hims & Hers is acquiring Australian telehealth platform Eucalyptus as part of its international expansion plan while using ...

HIMS expands its integrated telehealth ecosystem with a new weight-loss membership and a planned Eucalyptus acquisition to ...

Hims & Hers added eight new partners, expanding its Benefits program across fitness, nutrition, glucose monitoring, women's health and sleep. ・The company recently launched generic Semaglutide in ...

Hims is dealing with margin compression. While Hims management raised its revenue outlook for the year, it significantly lowered its adjusted EBITDA guidance. It now expects reven ...

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the expansion of Hims & Hers Benefits, adding eight new partners to the Hims & Her ...

Hims & Hers built massive weight-loss markets using telehealth. Peptides, if authorized by the FDA, stand to become a major ...

Hims & Hers continues growing rapidly, but shrinking margins and rising costs are beginning to test the company's long-term profitability story.

Hims & Hers (NYSE:HIMS) is dominating headlines this week because the GLP-1 darling just delivered one of the ugliest ...

Hims & Hers stock (NYSE: HIMS) increased by 16% yesterday following its announcement about expanding into the treatment of menopause and perimenopause—a strategic shift indicating that the company is ...

Hims & Hers Health is now offering generic semaglutide through its platform in Canada. This is Hims & Hers’ first international generic GLP-1 offering. Personalized treatment pl ...

Hims offers convenient, discreet prescription hair loss treatments for men. Learn if it's right for you and what to expect.

CHONGQING, CHINA - MAY 04: In this photo illustration, the logo of Hims & Hers Health, Inc. is displayed on a smartphone screen, with the company's stock market performance and candlestick chart ...